Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M944Revenue (TTM) $M824Net Margin (%)-57.3Altman Z-Score0.1
Enterprise Value $M1,595EPS (TTM) $-6.6Operating Margin %-59.9Piotroski F-Score3
P/E(ttm)--Beneish M-Score-5.8Pre-tax Margin (%)-69.9Higher ROA y-yN
Price/Book1.510-y EBITDA Growth Rate %--Quick Ratio1.4Cash flow > EarningsY
Price/Sales1.15-y EBITDA Growth Rate %--Current Ratio2.0Lower Leverage y-yN
Price/Free Cash Flow41.4y-y EBITDA Growth Rate %-391.1ROA % (ttm)-24.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-49.9Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M73.8ROIC % (ttm)-34.0Gross Margin Increase y-yN

Gurus Latest Trades with IPXL

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

IPXL is held by these investors:



IPXL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BENET LESLIE ZDirector 2016-08-15Sell10,092$22.81-43.88view
SCHLOSSBERG MARK ASVP and General Counsel 2015-09-11Sell7,457$43.3-70.44view
NESTOR MICHAELPresident, Impax Pharm. 2015-09-10Sell5,000$43.56-70.62view
FLEMING NIGELDirector 2015-08-31Sell29,166$41.02-68.8view
MARKBREITER MICHAELDirector 2015-08-31Sell28,000$41.7-69.3view
BENET LESLIE ZDirector 2015-08-31Sell20,000$40.92-68.72view
SCHLOSSBERG MARK ASVP and General Counsel 2015-08-27Sell4,649$43.41-70.51view
TERRERI PETER RDirector 2015-08-27Sell4,833$43.93-70.86view
MARKBREITER MICHAELDirector 2015-08-26Sell19,399$42.24-69.7view
HSU LARRYDirector 2014-06-06Sell100,000$28.38-54.9view

Quarterly/Annual Reports about IPXL:

News about IPXL:

Articles On GuruFocus.com
Teva: Good Value, Questionable Management? Jan 02 2017 
Integer Investments: Akorn Has 100% Upside Potential Jan 01 2017 
Sam Isaly Swaps 3 Health Care Stocks in Second Quarter Jul 29 2016 
Kyle Bass Sells Stakes in 11 Health Care Companies Mar 01 2016 
Alan Fournier Makes Modest Reductions in Middleby and Priceline Jan 12 2016 
Allergan Among Health Care Holdings in Alan Fournier's Portfolio Dec 15 2015 
Pharmaceutical Stocks Hold Prominent Positions in Kyle Bass' 3rd-Quarter Activity Nov 27 2015 
Kyle Bass Goes Fishing for These 3 New Holdings Nov 26 2015 
Alan Fournier's Highest Performing Stocks Jul 15 2015 
Alan Fournier's Most Heavily Weighted Trades In Q1 2015 May 28 2015 

More From Other Websites
Cellect Biotechnology and Impax Laboratories Post Solid Gains Mar 28 2017
IMPAX LABORATORIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement Mar 28 2017
Impax Laboratories, Inc. breached its 50 day moving average in a Bullish Manner : IPXL-US : March... Mar 28 2017
IMPAX LABORATORIES INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to... Mar 27 2017
Impax Gains 38% On CEO Appointment, Talk of Sale Mar 27 2017
Skincare Makers Lead Biotech Movers Mar 27 2017
8:14 am Impax Labs appoints Paul M. Bisaro as President and CEO effective immediately Mar 27 2017
Impax Board of Directors Appoints Paul M. Bisaro President and CEO Mar 27 2017
Falling Earnings Estimates Signal Weakness Ahead for Impax Laboratories (IPXL) Mar 22 2017
Impax Hires Morgan Stanley for Strategic Review, Possible Sale Mar 08 2017
Impax Labs downgraded by Susquehanna Mar 08 2017
Impax Laboratories, Inc. :IPXL-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017 Mar 07 2017
IMPAX LABORATORIES INC Financials Mar 07 2017
New Strong Sell Stocks for March 6th Mar 06 2017
Impax (IPXL) Q4 Earnings in Line, Revenues Miss Estimates Mar 02 2017
Impax Laboratories (IPXL) is Oversold: Can It Recover? Mar 02 2017
Edited Transcript of IPXL earnings conference call or presentation 1-Mar-17 1:30pm GMT Mar 01 2017
Biotech Premarket Movers: Impax, Clearside Biomedical, Mylan Mar 01 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)